New knee implant aims to repair cartilage and avoid repeat surgery
NCT ID NCT07332182
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new scaffold implant (MaioRegen Prime) to standard surgical cleaning (debridement) for treating deep cartilage lesions in the knee. About 400 patients aged 18-60 with knee lesions will be randomly assigned to one of the two procedures. The main goal is to see if the implant leads to better knee function and fewer complications or repeat surgeries over two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- osteochondral scaffold implant (MaioRegen Prime)
- What this could lead to
- If successful, this could offer a better surgical option for people with knee cartilage damage, potentially improving function and reducing the need for repeat surgeries.
- What could go wrong
- This is an early-stage study with no phase designation, and the implant may not prove superior to standard debridement. Risks include surgical complications, implant failure, or no significant benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.